No renal protection from volatile-anesthetic preconditioning in open heart surgery

Journal of Anesthesia

Volumn 27, Issue 1, 2013, Pages 48-55

  Sindhvananda, Wacharin ^a   Phisaiphun, Krit ^a   Prapongsena, Prut ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Acute kidney injury; Renal protection; Volatile anesthetic preconditioning

Indexed keywords

FENTANYL; INHALATION ANESTHETIC AGENT; ISOFLURANE; MORPHINE; SEVOFLURANE;

ACUTE KIDNEY FAILURE; ADULT; ANESTHETIC PRECONDITIONING; ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; POSTOPERATIVE CARE; PROPHYLAXIS; RENAL PROTECTION;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; ANESTHESIA, INTRAVENOUS; ANESTHETICS, INHALATION; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; FEMALE; GLOMERULAR FILTRATION RATE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SEX FACTORS; YOUNG ADULT;

EID: 84874113087     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-012-1461-z     Document Type: Article

References (37)

1. Koyner JL, Bennette MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, Kasza KE, O'Conor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74:1059-69.
2. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19-32.
3. Per-Olof J. Renal protection strategies in the perioperative period: best practice research. Clin Anesthesiol. 2004;18:645-60.
4. Tyagi P, Tayal G. Ischemic preconditioning of myocardium. Acta Pharmacol Sin. 2002;23:865-70.
5. Riksen NP, Smits P, Rongen GA. Ischaemic preconditioning: from molecular characterisation to clinical application-part II. Neth J Med. 2004;62:409-23.
6. Kato R, Foex P. Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anaesth. 2002;49:777-91.
7. Hawaleshka A, Jacobsohn E. Ischemic preconditioning: mechanisms and potential clinical applications. Can J Anaesth. 1998;45:670-82.
8. Hu ZY, Liu J. Mechanism of cardiac preconditioning with volatile anesthetics. Anesth Intensive Care. 2009;47:532-8.
9. Minquet G, Joris J, Lamy M. Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: a place for volatile anesthetics? Eur J Anaesthesiol. 2007;24:733-45.
10. Reiss ML, Stowe DF, Warltier DC. Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? Am J Physiol Heart Circ Physiol. 2004;286:H1603-7.
11. Stadnicka A, Marinovic J, Ljubkovic M, Bienengraeber MW, Bosnjak ZJ. Volatile-anesthetic-induced cardiac preconditioning. J Anesth. 2007;21:212-9.
12. Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG. Cardioprotection with volatile anesthetics in cardiac surgery. Asian Cardiovasc Thorac Ann. 2008;16:256-64.
13. 3 receptors. Am J Physiol Renal Physiol. 2000;278:F380-7.
14. Lee HT, Emala CW. Protein kinase C and Gi/o proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection. J Am Soc Nephrol. 2001;12:233-40.
15. + channels in renal ischemia reperfusion injury. Ren Fail. 2003;25:885-96.
16. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, Chassot PG, Schmid ER, Turina MI, von Segesser LK, Pasch T, Spahn DR, Zaugg M. Preconditioning by sevoflurane decreases biomarkers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology. 2003;98:1315-27.
17. Lorsomradee S, Cromheecke S, Lorsomradee S, De Hert SG. Effects of sevoflurane on biomechanical markers of hepatic and renal dysfunction after coronary artery surgery. J Cardiothorac Vasc Anesth. 2006;20:684-90.
18. De Hert SG. Volatile anesthetics and cardiac function. Semin Cardiothorac Vasc Anesth. 2006;10:33-42.
19. Kohn P. Renal insufficiency after cardiac surgery: a challenging clinical problem. Eur Heart J. 2009;30:1824-7.
20. Habbibey R, Pazoki-Toroudi H. Morphine dependence protects rat kidney against ischaemia-reperfusion injury. Clin Exp Pharmacol Physiol. 2008;35:1209-14.
21. Toosy N, McMorris ELJ, Grace PA, Mathie RT. Ischaemic preconditioning protects the rat kidney from reperfusion injury. BJU Int. 1999;84:489-94.
22. Rigalleau V, Lasseur C, Raffaitin C, Perlemoine C, Barthe N, Chauveau P, Combe C, Gin H. The Mayo clinic quadratic equation improves the prediction of glomerular filtration rate in diabetic subjects. Nephrol Dial Transplant. 2007;22:813-8.
23. Bakoush O, Grubb A, Rippe B. Inaccuracy of GFR predictions by plasma cystatin C in patients without kidney dysfunction and in advanced kidney disease. Clin Nephrol. 2008;69:331-8.
24. Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB. Biomarkers of acute renal injury and renal failure. Shock. 2006;26:245-53.
25. Kumar AB. Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology. 2011;114:964-70.
26. Munshi R, Hsu C, Himmelfarb J. Advances in understanding ischemic acute kidney injury. BMC Med. 2011;9:11.
27. Lee HT, Emala CW. Adenosine attenuates oxidant injury in human kidney proximal tubular cells via A1 and A2a adenosine receptors. Am J Physiol Renal Physiol. 2002;282:F844-52.
28. Lee HT, Emala CW. Preconditioning and adenosine protect human proximal tubule cells in an in vitro model of ischemic injury. J Am Soc Nephrol. 2002;13:2753-61.
29. Kim M, Kim M, Kim N, D'Agati VD, Emala CW, Lee HT. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways. Am J Physiol Renal Physiol. 2007;293:F1827-35.
30. 1 pathway. Am J Physiol Renal Physiol. 2008;295:F128-36.
31. Hashiquchi H, Morooka H, Miyoshi H, Matsumoto M, Koji T, Sumikawa K. Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinase, JNK and ERK. Anesth Analg. 2005;101:1584-9.
32. Adam F, Kauskot A, Rosa JP, Bryckaert M. Mitogen-activated protein kinases in hemostasis and thrombosis. J Thromb Haemost. 2008;6:2007-16.
33. Loveridge R, Schroeder F. Anaesthetic preconditioning. Contin Educ Anaesth Crit Care Pain. 2010;10:38-42.
34. Tesch GH. Review: serum and urine biomarkers of kidney disease: a pathophysiological perspective. Nephrology. 2010;15:609-16.
35. Borthwick E, Ferguson A. Perioperative acute kidney injury: risk factors, recognition, management and outcomes. BMJ. 2010;341:85-90.
36. Kher A, Meldrum KK, Wang M, Tsai BM, Pitcher JM, Meldrum DR. Cellular and molecular mechanism of sex differences in renal ischemia-reperfusion injury. Cardiovasc Res. 2005;67:594-603.
37. Neugarten J, Acharya A, Silbiger SR. Effects of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11:319-29.